Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 External links  





2 References  














Malcolm Brenner






العربية
Español
 

Edit links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 




In other projects  



Wikimedia Commons
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


Malcolm K. Brenner is a British clinical scientist working mostly in the field of gene therapy and immunotherapy applied to malignancy. In 2016, Dr. Brenner was elected to the National Academy of Medicine,[1] part of the National Academies of Sciences, Engineering, and Medicine.

He was educated at Forest School, Walthamstow and Emmanuel College, Cambridge England. He received his medical degree and subsequent Ph.D. from Cambridge University, England. In the 1980s, he was a Lecturer in Hematology at Royal Free Hospital in London. In 1990, he left the UK to work in St. Jude Children's Research HospitalinMemphis as the director of the Bone Marrow Transplant Division.

There, he conducted one of the first human gene therapy studies when he transduced bone marrow stem cells with a retroviral vector with the intention of marking them to study their survival and fate. This seminal study demonstrated that engrafted bone marrow stem cells contribute to long-term hematopoiesis and also that contaminating tumor cells in autografts can cause relapse. In 1994, he became the director of St. Jude's Cell and Gene Therapy Program.

The move in 1994 reflected his growing interest in the genetic-modification of T-cells for cancer therapy, cancer vaccines and monoclonal antibodies.[2]

He was President of the International Society for Cellular Therapy and President of the American Society of Gene Therapy in 2002–2003. He was appointed Editor in Chief of the journal Molecular Therapy in 2009.[3]

Dr. Brenner was appointed Director of the Center for Cell and Gene Therapy. Dr. Brenner's is a full-time faculty member for the Center for Cell and Gene Therapy, Texas Children's Cancer Center and the Dan L. Duncan Cancer Center at Baylor College of Medicine, Houston, Texas.[4] In 2017, Dr. Brenner was awarded the European Society of Gene and Cell Therapy Outstanding Achievement Award,[5] and in 2020 the Career Achievement Award in Cell & Gene Therapy from the International Society of Cell and Gene Therapy.[6]

[edit]

References

[edit]
  1. ^ "National Academy of Medicine Elects 80 New Members". 17 October 2016.
  • ^ Koehler, M; Hurwitz, CA; Krance, RA; Coustan-Smith, E; Williams, LL; Santana, V; Ribeiro, RC; Brenner, MK; Heslop, HE (1994). "XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors". Bone Marrow Transplant. 13 (5): 571–5. PMID 7519937.
  • ^ "Introducing Molecular Therapy— Methods & Clinical Development". Molecular Therapy. Archived from the original on 29 September 2013.
  • ^ Dr. Malcolm Brenner's Faculty Page, Texas Children's Cancer Center, retrieved 13 December 2013
  • ^ "ESGCT Awards". Archived from the original on 7 November 2017. Retrieved 1 November 2017.
  • ^ "Malcolm K. Brenner Receives the 2020 ISCT Career Achievement Award in Cell & Gene Therapy: Flexibility and Resilience Leads to Excellence in Clinical Research and Mentorship".
    1. Malcolm K. Brenner (22 September 2005). Allogeneic Stem Cell Transplantation and Other Immunotherapies for Pediatric Malignancies. Archived from the original on 14 April 2013. Retrieved 15 January 2024.
    2. "Giant Step for Gene Therapy". Time Magazine. Initial work on gene marking. 24 September 1990. Archived from the original on 13 April 2009. Retrieved 30 May 2007.
    3. "Center for Cell and Gene Therapy". Retrieved 30 May 2007.


  • t
  • e

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=Malcolm_Brenner&oldid=1216996119"

    Categories: 
    Living people
    Alumni of Emmanuel College, Cambridge
    British immunologists
    1951 births
    British scientist stubs
    Hidden categories: 
    BLP articles lacking sources from March 2024
    All BLP articles lacking sources
    Use dmy dates from April 2022
    Webarchive template wayback links
    Articles with ORCID identifiers
    All stub articles
     



    This page was last edited on 3 April 2024, at 05:22 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki